Phase
Condition
Carcinoma
Treatment
BioPearl™
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subject is at least 18 years old
Subject with HCC confirmed by histology or according to the latest applicableversion of EASL (the European Association for the Study of the Liver) criteria
Subject with tumor(s) < 5 cm and within the up-to-7 criteria: the sum of thediameter of the largest tumor (in cm) and the number of tumors must be ≤ 7.0
Subject with BCLC (Barcelona Clinic Liver Cancer) Stage A or B classification who isnot a candidate for curative treatment at the time of study inclusion
Subject with treatment failure/recurrence after a prior resection/ablation ispermitted, with the exception of recurrence in the segment of a prior thermalablation
WHO (World Health Organization) or ECOG (Eastern Cooperative Oncology Group)performance status 0 or 1
Subject deemed treatable in one session for initial treatment
Normal liver or compensated cirrhosis with preserved liver function (Child-PughClass A)
Total bilirubin ≤ 2.0 mg/dl
Adequate bone marrow function: Hemoglobin ≥ 9g/dl, absolute neutrophil count ≥ 1.0 x 109/L, platelet count ≥ 75 x 109/L
Subject with no ascites or with minor ascites controlled by sodium dietaryrestrictions (subject receiving diuretic treatment or paracentesis is not eligible)
Adequate renal function: serum creatinine < 1.5 X ULN (Upper Limit of Normal)
Subject has provided written informed consent
Subjects of childbearing/reproductive potential should use adequate birth controlmeasures, during the study treatment period until survival follow-up
Exclusion
Exclusion Criteria:
Subject previously treated with any systemic therapy for HCC
Subject previously treated with intra-arterial loco-regional therapy for HCC
Eligible for curative treatment at the time of study inclusion
Recurrence in the segment of a prior thermal ablation
Advanced liver disease: Child-Pugh's B-C class or active gastrointestinal bleeding,encephalopathy
Advanced tumoral disease: BCLC class C or D (vascular invasion - even segmental,extra-hepatic spread or cancer-related symptoms performance status >1)
History of another primary tumor. Exceptions include: A. Malignancy treated with curative intent ≥ 5 years before inclusion and with noknown active disease B. Malignancy which occurred < 5 years before, not active and not expected to recuror be clinically relevant in the next 5 years
Subject with history of biliary tree disease or biliary dilatation
Portal vein thrombosis, porto-systemic shunt, hepatofugal blood flow or absentportal blood flow in the liver area to be treated
Contraindication to multiphasic CT and MRI (e.g. allergy to contrast media)
Any other contraindication for embolization procedure or Doxorubicin treatment
Subject is currently participating in an investigational drug or device study thathas not completed the primary endpoint or that clinically interferes with thecurrent study endpoints Note: Trials requiring extended follow-up for products that were investigational,but have become commercially available since then, are not consideredinvestigational trials
In the Investigator's opinion subject has (a) co-morbid condition(s) that couldlimit the subject's ability to participate in the study, compliance with follow-uprequirements or impact the scientific integrity of the study
Pregnant or breast-feeding woman
Study Design
Study Description
Connect with a study center
CUB Hôpital Erasme
Brussels,
BelgiumActive - Recruiting
UZ Leuven
Leuven,
BelgiumActive - Recruiting
Beaujon Hospital
Clichy,
FranceActive - Recruiting
CHU Grenobles (Hôpital Michallon)
La Tronche,
FranceSite Not Available
Paul-Brousse Hospital
Villejuif,
FranceActive - Recruiting
SLK-Kliniken Heilbronn
Heilbronn,
GermanyActive - Recruiting
University Hospital Tübingen
Tübingen,
GermanyActive - Recruiting
Fondazione IRCCS Instituto Tumori
Milan,
ItalyActive - Recruiting
Fondazione Policlinico Universitario A. Gemelli
Rome,
ItalyActive - Recruiting
Città della Salute e della Scienza di Torino
Turin,
ItalyActive - Recruiting
Città della Salute e della Scienza di Torino Presidio Molinette
Turin,
ItalySite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.